annual CFO:
$572.84M+$413.58M(+259.69%)Summary
- As of today (June 28, 2025), BMRN annual cash flow from operations is $572.84 million, with the most recent change of +$413.58 million (+259.69%) on December 31, 2024.
- During the last 3 years, BMRN annual CFO has risen by +$268.31 million (+88.10%).
- BMRN annual CFO is now at all-time high.
Performance
BMRN Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
$174.39M-$11.23M(-6.05%)Summary
- As of today (June 28, 2025), BMRN quarterly cash flow from operations is $174.39 million, with the most recent change of -$11.23 million (-6.05%) on March 31, 2025.
- Over the past year, BMRN quarterly CFO has increased by +$127.42 million (+271.28%).
- BMRN quarterly CFO is now -21.26% below its all-time high of $221.48 million, reached on September 30, 2024.
Performance
BMRN quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
$700.26M+$127.42M(+22.24%)Summary
- As of today (June 28, 2025), BMRN TTM cash flow from operations is $700.26 million, with the most recent change of +$127.42 million (+22.24%) on March 31, 2025.
- Over the past year, BMRN TTM CFO has increased by +$420.10 million (+149.95%).
- BMRN TTM CFO is now at all-time high.
Performance
BMRN TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
BMRN Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +259.7% | +271.3% | +149.9% |
| 3 y3 years | +88.1% | +483.9% | +381.0% |
| 5 y5 years | +1086.9% | +1247.8% | +696.3% |
BMRN Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +259.7% | -21.3% | +335.9% | at high | +488.3% |
| 5 y | 5-year | at high | +1086.9% | -21.3% | +335.9% | at high | +720.3% |
| alltime | all time | at high | +351.4% | -21.3% | +201.7% | at high | +338.6% |
BMRN Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $174.39M(-6.1%) | $700.26M(+22.2%) |
| Dec 2024 | $572.84M(+259.7%) | $185.63M(-16.2%) | $572.84M(+38.1%) |
| Sep 2024 | - | $221.48M(+86.5%) | $414.70M(+26.1%) |
| Jun 2024 | - | $118.76M(+152.8%) | $328.86M(+17.4%) |
| Mar 2024 | - | $46.97M(+70.9%) | $280.16M(+75.9%) |
| Dec 2023 | $159.26M(-9.5%) | $27.48M(-79.7%) | $159.26M(+14.9%) |
| Sep 2023 | - | $135.65M(+93.6%) | $138.56M(-14.1%) |
| Jun 2023 | - | $70.06M(-194.8%) | $161.24M(+9.4%) |
| Mar 2023 | - | -$73.93M(-1189.5%) | $147.40M(-16.2%) |
| Dec 2022 | $175.90M(-42.2%) | $6.79M(-95.7%) | $175.90M(-2.4%) |
| Sep 2022 | - | $158.32M(+181.6%) | $180.30M(+51.5%) |
| Jun 2022 | - | $56.23M(-223.8%) | $119.03M(-18.2%) |
| Mar 2022 | - | -$45.43M(-506.4%) | $145.59M(-52.2%) |
| Dec 2021 | $304.54M(+256.7%) | $11.18M(-88.5%) | $304.54M(+8.8%) |
| Sep 2021 | - | $97.06M(+17.2%) | $279.97M(+4.0%) |
| Jun 2021 | - | $82.78M(-27.1%) | $269.12M(+25.7%) |
| Mar 2021 | - | $113.51M(-948.1%) | $214.07M(+150.8%) |
| Dec 2020 | $85.36M(+76.9%) | -$13.38M(-115.5%) | $85.36M(-45.3%) |
| Sep 2020 | - | $86.21M(+210.8%) | $156.09M(+11.5%) |
| Jun 2020 | - | $27.74M(-282.6%) | $140.01M(+59.2%) |
| Mar 2020 | - | -$15.19M(-126.5%) | $87.94M(+82.2%) |
| Dec 2019 | $48.26M(+138.8%) | $57.34M(-18.2%) | $48.26M(+19.8%) |
| Sep 2019 | - | $70.13M(-388.1%) | $40.29M(+132.0%) |
| Jun 2019 | - | -$24.34M(-55.6%) | $17.37M(+121.3%) |
| Mar 2019 | - | -$54.87M(-211.1%) | $7.85M(-61.2%) |
| Dec 2018 | $20.21M(-330.8%) | $49.37M(+4.6%) | $20.21M(-238.9%) |
| Sep 2018 | - | $47.20M(-239.4%) | -$14.55M(-38.0%) |
| Jun 2018 | - | -$33.86M(-20.4%) | -$23.46M(-180.4%) |
| Mar 2018 | - | -$42.51M(-390.9%) | $29.18M(-433.2%) |
| Dec 2017 | -$8.76M(-96.2%) | $14.61M(-61.8%) | -$8.76M(-62.9%) |
| Sep 2017 | - | $38.29M(+103.9%) | -$23.58M(-67.4%) |
| Jun 2017 | - | $18.78M(-123.3%) | -$72.24M(-47.2%) |
| Mar 2017 | - | -$80.44M(>+9900.0%) | -$136.83M(-39.9%) |
| Dec 2016 | -$227.84M(+3.8%) | -$210.00K(-98.0%) | -$227.84M(-22.4%) |
| Sep 2016 | - | -$10.37M(-77.4%) | -$293.47M(+2.6%) |
| Jun 2016 | - | -$45.80M(-73.3%) | -$285.96M(+13.0%) |
| Mar 2016 | - | -$171.45M(+160.4%) | -$253.14M(+15.3%) |
| Dec 2015 | -$219.50M(+211.7%) | -$65.85M(+2210.4%) | -$219.50M(+23.6%) |
| Sep 2015 | - | -$2.85M(-78.1%) | -$177.56M(-3.1%) |
| Jun 2015 | - | -$12.99M(-90.6%) | -$183.27M(+0.8%) |
| Mar 2015 | - | -$137.81M(+476.4%) | -$181.74M(+158.1%) |
| Dec 2014 | -$70.42M(+22.8%) | -$23.91M(+179.4%) | -$70.42M(+26.9%) |
| Sep 2014 | - | -$8.56M(-25.4%) | -$55.51M(-1.7%) |
| Jun 2014 | - | -$11.46M(-56.7%) | -$56.45M(+9.0%) |
| Mar 2014 | - | -$26.49M(+194.5%) | -$51.80M(-9.7%) |
| Dec 2013 | -$57.34M(-425.6%) | -$9.00M(-5.2%) | -$57.34M(+57.7%) |
| Sep 2013 | - | -$9.49M(+39.2%) | -$36.35M(+187.5%) |
| Jun 2013 | - | -$6.82M(-78.7%) | -$12.65M(+74.5%) |
| Mar 2013 | - | -$32.03M(-367.2%) | -$7.25M(-141.2%) |
| Dec 2012 | $17.61M(-4.4%) | $11.99M(-15.7%) | $17.61M(+244.6%) |
| Sep 2012 | - | $14.21M(-1101.0%) | $5.11M(-2202.9%) |
| Jun 2012 | - | -$1.42M(-80.2%) | -$243.00K(-101.6%) |
| Mar 2012 | - | -$7.17M(+1297.9%) | $14.74M(-19.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | $18.41M(-1.8%) | -$513.00K(-105.8%) | $18.41M(+485.3%) |
| Sep 2011 | - | $8.86M(-34.7%) | $3.15M(-5.9%) |
| Jun 2011 | - | $13.57M(-487.7%) | $3.34M(-72.1%) |
| Mar 2011 | - | -$3.50M(-77.8%) | $12.00M(-36.0%) |
| Dec 2010 | $18.75M(-78.6%) | -$15.78M(-274.3%) | $18.75M(-65.3%) |
| Sep 2010 | - | $9.06M(-59.2%) | $53.99M(-26.4%) |
| Jun 2010 | - | $22.22M(+583.7%) | $73.37M(+3.4%) |
| Mar 2010 | - | $3.25M(-83.3%) | $70.96M(-19.1%) |
| Dec 2009 | $87.73M(-1056.2%) | $19.47M(-31.5%) | $87.73M(+22.6%) |
| Sep 2009 | - | $28.43M(+43.5%) | $71.58M(+52.6%) |
| Jun 2009 | - | $19.81M(-1.0%) | $46.90M(+41.8%) |
| Mar 2009 | - | $20.02M(+504.1%) | $33.06M(-460.4%) |
| Dec 2008 | -$9.18M(-73.4%) | $3.31M(-11.7%) | -$9.18M(-12.1%) |
| Sep 2008 | - | $3.75M(-37.2%) | -$10.44M(-56.3%) |
| Jun 2008 | - | $5.98M(-126.9%) | -$23.91M(-34.6%) |
| Mar 2008 | - | -$22.22M(-1185.5%) | -$36.57M(+6.0%) |
| Dec 2007 | -$34.49M(-33.9%) | $2.05M(-121.1%) | -$34.49M(-30.1%) |
| Sep 2007 | - | -$9.72M(+45.5%) | -$49.35M(-5.4%) |
| Jun 2007 | - | -$6.68M(-66.8%) | -$52.18M(-1.4%) |
| Mar 2007 | - | -$20.15M(+57.3%) | -$52.94M(+1.5%) |
| Dec 2006 | -$52.17M(-11.8%) | -$12.81M(+2.1%) | -$52.17M(-4.3%) |
| Sep 2006 | - | -$12.55M(+68.7%) | -$54.50M(-14.9%) |
| Jun 2006 | - | -$7.44M(-61.6%) | -$64.04M(+6.5%) |
| Mar 2006 | - | -$19.38M(+28.0%) | -$60.12M(+1.6%) |
| Dec 2005 | -$59.15M(+15.9%) | -$15.14M(-31.4%) | -$59.15M(+14.2%) |
| Sep 2005 | - | -$22.08M(+526.6%) | -$51.81M(+19.0%) |
| Jun 2005 | - | -$3.52M(-80.9%) | -$43.54M(-24.1%) |
| Mar 2005 | - | -$18.40M(+135.9%) | -$57.36M(+12.4%) |
| Dec 2004 | -$51.05M(-31.8%) | -$7.80M(-43.5%) | -$51.05M(-33.0%) |
| Sep 2004 | - | -$13.81M(-20.3%) | -$76.23M(-10.4%) |
| Jun 2004 | - | -$17.34M(+43.4%) | -$85.06M(+13.3%) |
| Mar 2004 | - | -$12.09M(-63.3%) | -$75.10M(+0.4%) |
| Dec 2003 | -$74.80M(+39.6%) | -$32.99M(+45.7%) | -$74.80M(-1.6%) |
| Sep 2003 | - | -$22.64M(+206.9%) | -$76.01M(+27.7%) |
| Jun 2003 | - | -$7.38M(-37.5%) | -$59.52M(+4.3%) |
| Mar 2003 | - | -$11.80M(-65.5%) | -$57.06M(+6.5%) |
| Dec 2002 | -$53.59M(+31.2%) | -$34.20M(+456.0%) | -$53.59M(+25.1%) |
| Sep 2002 | - | -$6.15M(+25.2%) | -$42.84M(+0.2%) |
| Jun 2002 | - | -$4.91M(-41.1%) | -$42.78M(+6.9%) |
| Mar 2002 | - | -$8.33M(-64.5%) | -$40.03M(-2.0%) |
| Dec 2001 | -$40.85M(+220.8%) | -$23.45M(+285.3%) | -$40.85M(+103.2%) |
| Sep 2001 | - | -$6.09M(+181.5%) | -$20.11M(+28.2%) |
| Jun 2001 | - | -$2.16M(-76.4%) | -$15.69M(-2.2%) |
| Mar 2001 | - | -$9.15M(+238.3%) | -$16.04M(+26.0%) |
| Dec 2000 | -$12.73M(-1.6%) | -$2.71M(+62.6%) | -$12.73M(-3.3%) |
| Sep 2000 | - | -$1.66M(-34.0%) | -$13.17M(-27.7%) |
| Jun 2000 | - | -$2.52M(-56.9%) | -$18.20M(+23.9%) |
| Mar 2000 | - | -$5.84M(+86.1%) | -$14.69M(+13.5%) |
| Dec 1999 | -$12.94M(+59.8%) | -$3.14M(-53.1%) | -$12.94M(+32.0%) |
| Sep 1999 | - | -$6.70M(-773.4%) | -$9.80M(+216.1%) |
| Jun 1999 | - | $995.00K(-124.3%) | -$3.10M(-24.3%) |
| Mar 1999 | - | -$4.09M | -$4.09M |
| Dec 1998 | -$8.10M | - | - |
FAQ
- What is BioMarin Pharmaceutical annual cash flow from operations?
- What is the all time high annual CFO for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical annual CFO year-on-year change?
- What is BioMarin Pharmaceutical quarterly cash flow from operations?
- What is the all time high quarterly CFO for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical quarterly CFO year-on-year change?
- What is BioMarin Pharmaceutical TTM cash flow from operations?
- What is the all time high TTM CFO for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical TTM CFO year-on-year change?
What is BioMarin Pharmaceutical annual cash flow from operations?
The current annual CFO of BMRN is $572.84M
What is the all time high annual CFO for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high annual cash flow from operations is $572.84M
What is BioMarin Pharmaceutical annual CFO year-on-year change?
Over the past year, BMRN annual cash flow from operations has changed by +$413.58M (+259.69%)
What is BioMarin Pharmaceutical quarterly cash flow from operations?
The current quarterly CFO of BMRN is $174.39M
What is the all time high quarterly CFO for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high quarterly cash flow from operations is $221.48M
What is BioMarin Pharmaceutical quarterly CFO year-on-year change?
Over the past year, BMRN quarterly cash flow from operations has changed by +$127.42M (+271.28%)
What is BioMarin Pharmaceutical TTM cash flow from operations?
The current TTM CFO of BMRN is $700.26M
What is the all time high TTM CFO for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high TTM cash flow from operations is $700.26M
What is BioMarin Pharmaceutical TTM CFO year-on-year change?
Over the past year, BMRN TTM cash flow from operations has changed by +$420.10M (+149.95%)